TY - JOUR
T1 - PET/CT enterography in Crohn disease
T2 - Correlation of disease activity on CT enterography with18F-FDG uptake
AU - Groshar, David
AU - Bernstine, Hanna
AU - Stern, Dorit
AU - Sosna, Jacob
AU - Eligalashvili, Merab
AU - Gurbuz, Evren G.
AU - Niv, Yaron
AU - Fraser, Gerald
PY - 2010/7
Y1 - 2010/7
N2 - We combined18F-FDG PET and CT enterography in a single examination and compared the level of18F-FDG uptake measured by maximal standardized uptake value (SUVmax) with the CT enterography patterns of disease activity found in patients with Crohn disease (CD). Methods: Twenty-eight patients (mean age, 37.5 y; 11 male and 17 female) suspected of having active CD underwent PET/CT enterography. Abnormal bowel segments recognized on CT enterography were graded qualitatively for the presence of perienteric fat infiltration, the comb sign, and intramural attenuation and by quantitative measurements of mural enhancement (Hounsfield units) and thickness (mm). Also, for each patient, normal segments of the ileum and colon were noted, and CT enterography measurements of thickness and enhancement were obtained. For segments detected on CT enterography, a volume of interest was placed on the fused18F-FDG PET scan, and the SUVmax was obtained. Results: Ofthe28 patients with suspected active CD, 22 had 85 abnormal segments and 6 had no abnormal segments. SUVmax was significantly higher in the abnormal segments than in the normal segments (5.0 ± 2.5 [95% confidence interval, 4.5-5.5] and 2.1 ± 0.69 [95% confidence interval, 1.9-2.2], respectively; P < 0.0001). A good correlation was found between SUVmax with CT enterography measurements of mural thickness and enhancement (P < 0.00001). There was a significant difference in SUVmax between the 3 levels of disease activity found by intramural attenuation, perienteric fat infiltration, and the comb signonCT enterography. SUVmax was significantly higher when there were intense CT enterography findings of active disease (P< 0.001). Conclusion: SUVmax assessment may allow an objective, reliable indication of the grade and severity of inflammation activity in abnormal segments of the bowel detected by CT enterography. COPYRIGHT
AB - We combined18F-FDG PET and CT enterography in a single examination and compared the level of18F-FDG uptake measured by maximal standardized uptake value (SUVmax) with the CT enterography patterns of disease activity found in patients with Crohn disease (CD). Methods: Twenty-eight patients (mean age, 37.5 y; 11 male and 17 female) suspected of having active CD underwent PET/CT enterography. Abnormal bowel segments recognized on CT enterography were graded qualitatively for the presence of perienteric fat infiltration, the comb sign, and intramural attenuation and by quantitative measurements of mural enhancement (Hounsfield units) and thickness (mm). Also, for each patient, normal segments of the ileum and colon were noted, and CT enterography measurements of thickness and enhancement were obtained. For segments detected on CT enterography, a volume of interest was placed on the fused18F-FDG PET scan, and the SUVmax was obtained. Results: Ofthe28 patients with suspected active CD, 22 had 85 abnormal segments and 6 had no abnormal segments. SUVmax was significantly higher in the abnormal segments than in the normal segments (5.0 ± 2.5 [95% confidence interval, 4.5-5.5] and 2.1 ± 0.69 [95% confidence interval, 1.9-2.2], respectively; P < 0.0001). A good correlation was found between SUVmax with CT enterography measurements of mural thickness and enhancement (P < 0.00001). There was a significant difference in SUVmax between the 3 levels of disease activity found by intramural attenuation, perienteric fat infiltration, and the comb signonCT enterography. SUVmax was significantly higher when there were intense CT enterography findings of active disease (P< 0.001). Conclusion: SUVmax assessment may allow an objective, reliable indication of the grade and severity of inflammation activity in abnormal segments of the bowel detected by CT enterography. COPYRIGHT
KW - Correlative imaging
KW - Crohn disease
KW - FDG
KW - Gastroenterology
KW - PET/CT
UR - http://www.scopus.com/inward/record.url?scp=77954963361&partnerID=8YFLogxK
U2 - 10.2967/jnumed.109.073130
DO - 10.2967/jnumed.109.073130
M3 - ???researchoutput.researchoutputtypes.contributiontojournal.article???
C2 - 20554741
AN - SCOPUS:77954963361
SN - 0161-5505
VL - 51
SP - 1009
EP - 1014
JO - Journal of Nuclear Medicine
JF - Journal of Nuclear Medicine
IS - 7
ER -